| Photodynamic Therapy With Metil 5-aminolevulinate for Actinic Cheilitis - Phase 2 Clinical Trial (NCT03990636) | Instituto Nacional de Cancer, Brazil | 2019-10-17 |
| A Trial of Brexpiprazole in the Treatment of Borderline Personality Disorder (NCT04100096) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2019-10-17 |
| Evaluation of AL3818 in Combination With Nivolumab in Solid Tumors (NCT04165330) | Sarcoma Oncology Research Center, LLC | 2019-10-17 |
| Avelumab in Combination With Hypofractionated Radiotherapy in Patients With Relapsed Refractory Multiple Myeloma (NCT03910439) | National Cancer Institute (NCI) | 2019-10-17 |
| Tolerance of Intraperitoneal (IP) Nivolumab After Extensive Debulking Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Ovarian Carcinoma (NCT03959761) | Hospices Civils de Lyon | 2019-10-17 |
| Intravenous (IV) Vitamin C With Chemotherapy for Cisplatin Ineligible Bladder Cancer Patients (NCT04046094) | University of Kansas Medical Center | 2019-10-17 |
| Treatment Safety and Efficacy of Pro-ocular™ 1% for Chronic Ocular Graft Following Allogeneic HSCT. (NCT03990051) | Glia, LLC | 2019-10-17 |
| Effect and Safety of Apatinib on Radiation-Induced Brain Injury (NCT04152681) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2019-10-17 |
| Alendronate Versus Denosumab in Kidney Transplant Patients (NCT04169698) | Ain Shams University | 2019-10-17 |
| A Study to Compare ORMD-0801 Once Daily to ORMD-0801 Three Times Daily in Subjects With Type 1 Diabetes (NCT04150107) | Oramed, Ltd. | 2019-10-17 |
| A Clinical Study of SHP674 (Pegaspargase) in Participants With Newly Diagnosed, Untreated Acute Lymphoblastic Leukemia (NCT04067518) | Institut de Recherches Internationales Servier | 2019-10-17 |
| A Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in Japanese Subjects With Palmoplantar Pustulosis (NCT04057937) | Amgen | 2019-10-16 |
| A Study With NLY01 in Subjects With Type 2 Diabetes (NCT04159766) | Neuraly, Inc. | 2019-10-16 |
| A Study to Evaluate the Safety and Efficacy of Crizanlizumab in Sickle Cell Disease Related Priapism (NCT03938454) | Novartis Pharmaceuticals | 2019-10-16 |
| Studying the Biology of IDH-mutant Gliomas Via Longitudinal Observation of 2-hydroxyglutarate (2-HG) Using MR Spectroscopy (NCT03952598) | National Cancer Institute (NCI) | 2019-10-16 |
| CLIC-1901 for the Treatment of Patients With Relapsed/Refractory CD19 Positive Hematologic Malignancies (NCT03765177) | Ottawa Hospital Research Institute | 2019-10-16 |
| A Study to Evaluate the Safety and Efficacy of Bermekimab in Patients With Moderate to Severe Atopic Dermatitis (NCT04021862) | Janssen Research & Development, LLC | 2019-10-16 |
| A Study of Lazertinib in Participants With Epidermal Growth Factor Receptor (EGFR) Mutation Positive Advanced Non-Small Cell Lung Cancer (NSCLC) (NCT04075396) | Janssen Research & Development, LLC | 2019-10-16 |
| Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination Therapy (NCT04068896) | NGM Biopharmaceuticals, Inc | 2019-10-16 |
| High Dose Steroid Therapy (Prednisone or Methylprednisolone) for the Improvement of Symptoms of Late Radiation-Associated Lower Cranial Neuropathy in Oropharyngeal Cancer Survivors (NCT04151082) | M.D. Anderson Cancer Center | 2019-10-16 |
| Bacille Calmette Guerin (BCG) Revaccination of Healthy Adolescents for the Prevention of Mycobacterium Tuberculosis Sustained Infection (NCT04152161) | Gates Medical Research Institute | 2019-10-16 |
| Nivolumab and Ipilimumab in T1aN0M0 Renal Cell Carcinoma Patients Ineligible for Surgical Treatment. (NCT04134182) | Kidney Cancer Research Bureau | 2019-10-16 |
| Pazopanib Vs. Pazopanib Plus Gemcitabine (NCT02203760) | North Eastern German Society of Gynaecological Oncology | 2019-10-16 |
| A Study of TAK-981 Given With Rituximab in Adults With Relapsed or Refractory CD20-Positive Non-Hodgkin Lymphoma (NCT04074330) | Takeda | 2019-10-15 |
| Evaluation of a Combination of Plant Extracts (BSL_EP028) on Joint Mobility (NCT04029792) | Biosearch S.A. | 2019-10-15 |
| Budesonide With Intratracheal Surfactants in Extremely Preterm Infants (NCT04019106) | University of Manitoba | 2019-10-15 |
| Effects of Triple Drug Cocktail Therapy on Metabolic, Endocrine Alterations and Perceived Stress in Patients With Poly Cystic Ovary Syndrome (NCT04113889) | Khyber Medical University Peshawar | 2019-10-15 |
| Single Non-fasting OGTT Versus Fasting OGTT for Screening of Hyperglycaemia in Pregnancy (HIP) (NCT04129190) | Isra University | 2019-10-15 |
| Zanubrutinib (BGB-3111) in Participants With Previously Treated B-Cell Lymphoma Intolerant of Prior Bruton Tyrosine Kinase Inhibitor (BTKi) Treatment (NCT04116437) | BeiGene | 2019-10-15 |
| Marrow Infiltrating Lymphocytes - Non-Small Cell Lung Cancer (MILs™ - NSCLC) Alone or in Combination With Nivolumab With or Without Tadalafil in Locally Advanced and Unresectable or Metastatic NSCLC (NCT04069936) | WindMIL Therapeutics | 2019-10-15 |
| PHOENIX DDR/Anti-PD-L1 Trial: A Pre-surgical Window of Opportunity and Post-surgical Adjuvant Biomarker Study of DNA Damage Response Inhibition With or Without Anti-PD-L1 Immunotherapy in Patients With Neoadjuvant Treatment Resistant Residual Triple Negative Breast Cancer (NCT03740893) | Institute of Cancer Research, United Kingdom | 2019-10-15 |
| A Clinical Study to Enable Process Validation of Commercial Grade OTL-101 (NCT04140539) | University of California, Los Angeles | 2019-10-15 |
| Trial to Assess Safety and Efficacy of MOR202 in Anti-PLA2R + Membranous Nephropathy (aMN) (NCT04145440) | HI-Bio, A Biogen Company | 2019-10-15 |
| rTMS on Motor Function of Parkinson's Disease Patients With Different Phenotypes (NCT04116216) | Universidade Federal de Pernambuco | 2019-10-15 |
| Suprafascial Vancomycin Powder for Prevention of Surgical Site Infections After Instrumented Posterior Spinal Fusion (NCT04017468) | Insel Gruppe AG, University Hospital Bern | 2019-10-15 |
| Evaluation of EB01 Cream for the Treatment of Chronic Allergic Contact Dermatitis (NCT03680131) | Edesa Biotech Inc. | 2019-10-15 |
| Natural Killer (NK) Cell Therapy in Locally Advanced HCC (NCT05040438) | Vaxcell Bio, Co., Ltd. | 2019-10-15 |
| Mechanistic Study of Anti-inflammatory Effects of Fevipiprant in Patients With Eosinophilic Asthma. (NCT03989635) | Novartis Pharmaceuticals | 2019-10-15 |
| Niraparib and Panitumumab in Patients With Advanced or Metastatic Colorectal Cancer (NCT03983993) | Emory University | 2019-10-15 |
| A 24-Week Study of Topical Pirenzepine or Placebo in Type 2 Diabetic Patients (T2DM) With Peripheral Neuropathy (NCT04005287) | WinSanTor, Inc | 2019-10-15 |
| Dutasteride Treatment for Reducing Heavy Drinking in AUD: Predictors of Efficacy (NCT04098302) | UConn Health | 2019-10-15 |
| Study of Sacituzumab Govitecan in Participants With Metastatic Solid Tumors (NCT03964727) | Gilead Sciences | 2019-10-15 |
| Efficacy, Safety and Tolerability of Enteric-Coated Cholestyramine Capsules for Adult Short Bowel Syndrome (NCT04046328) | Pharmascience Inc. | 2019-10-15 |
| A 16 Week Study to Evaluate the Efficacy and Safety of PF-06882961 in Adults With Type 2 Diabetes Mellitus (NCT03985293) | Pfizer | 2019-10-15 |
| Efficacy of metfOrmin in PrevenTIng Glucocorticoid-induced Diabetes in Patients With Brain Metastases (NCT04001725) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2019-10-15 |
| Efficacy and Safety of Angong Niuhuang Wan for Stroke (NCT04236427) | Chinese University of Hong Kong | 2019-10-15 |
| Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01) (NCT04150497) | Cellectis S.A. | 2019-10-14 |
| Niraparib in Combination with Cabozantinib (XL184) in Patients with Advanced Urothelial Cancer (NICARAGUA) (NCT03425201) | Fundacion CRIS de Investigación para Vencer el Cáncer | 2019-10-14 |
| Optimal Timing of BR55 CEUS of the Ovaries (NCT04248153) | Bracco Diagnostics, Inc | 2019-10-14 |
| Dose Ranging Study to Assess the Efficacy and Safety of Voclosporin Ophthalmic Solution in Subjects With Dry Eye Syndrome (NCT04147650) | Aurinia Pharmaceuticals Inc. | 2019-10-14 |
| Brain Network Changes Accompanying and Predicting Responses to Pharmacotherapy in OCD (NCT04131829) | Yale University | 2019-10-14 |
| Optune Device - TT Field Plus Nivolumab and Ipilimumab for Melanoma With Brain Metastasis (NCT03903640) | Washington University School of Medicine | 2019-10-14 |
| Study on the Effectiveness and Safety of the Combination of the Two Drugs Regorafenib and Nivolumab in Patients With Colorectal Cancer (Cancer of the Colon or Rectum Classified as Proficient Mismatch Repair and Microsatellite Stable) (NCT04126733) | Bayer | 2019-10-14 |
| Evaluation of a Treatment With Allopurinol in Adenylosuccinate Lyase Deficiency (NCT03776656) | Assistance Publique - Hôpitaux de Paris | 2019-10-14 |
| Inulin for Infections in the Intensive Care Unit (NCT03865706) | Columbia University | 2019-10-14 |
| A Study to Evaluate the Safety and Efficacy(Immunogenicity) of GC3111 in Healthy Adults (NCT04238975) | Green Cross Corporation | 2019-10-14 |
| Linaclotide Safety and Efficacy in 2 to 5-Year-Old Participants With Functional Constipation (NCT04110145) | Allergan | 2019-10-14 |
| Novel Cognitive Treatment Targets for Epidiolex in Sturge- Weber Syndrome (NCT04447846) | Anne Comi, MD | 2019-10-14 |
| Clinical Study on the First-line Treatment of Advanced Biliary System Tumors With Tripley Monoclonal Antibody Combined With GEMOX Regimen (NCT04191343) | Zhejiang Cancer Hospital | 2019-10-14 |
| Efficacy of Perioperative Chemotherapy Plus PD-1 Antibody in the Locally Advanced Gastric Cancer (NCT04250948) | Sun Yat-sen University | 2019-10-12 |
| Study of CD19 Specific Chimeric Antigen Receptor Positive T Cells (CAR-T) in ALL and NHL (NCT04206943) | Acibadem University | 2019-10-12 |
| Effects of Conbercept in Refractory Uveitic Macular Edema and VEGF (NCT04296838) | Peking Union Medical College Hospital | 2019-10-12 |
| Platinum-doublet Chemotherapy and Nivolumab for the Treatment of Subjects With Neuroendocrine Neoplasms (NENs) of the Gastroenteropancreatic (GEP) Tract or of Unknown (UK) Origin. (NCT03980925) | Grupo Espanol de Tumores Neuroendocrinos | 2019-10-11 |
| Spheroidal Mesenchymal Stem Cells in Retinitis Pigmentosa (NCT05712148) | Acibadem University | 2019-10-11 |
| CAPOXIRI+Bevacizumab vs. FOLFOXIRI+Bevacizumab for mCRC (NCT04097444) | Chugai Pharmaceutical | 2019-10-11 |
| Study of Oral SKI-O-703, SYK Inhibitor, in Patients With Persistent and Chronic Immune Thrombocytopenia (ITP) (NCT04056195) | Oscotec Inc. | 2019-10-11 |
| Phase II Trial of Neoadjuvant Pembrolizumab for Patients With Early Stage Gastroesophageal Adenocarcinoma (NCT04089904) | University of Chicago | 2019-10-11 |
| Allogeneic Adoptive Immune Therapy for Advanced AIDS Patients (NCT04098770) | Beijing 302 Hospital | 2019-10-11 |
| Acalabrutinib and Venetoclax Treatment of Newly Diagnosed Patients With CLL at High Risk of Infection or Early Treatment (NCT03868722) | Rigshospitalet, Denmark | 2019-10-11 |
| Gonyautoxin 2/3 in the Treatment of Acute Back Pain: A Clinical Proof-of-concept Study (NCT04799041) | Algenis SpA | 2019-10-11 |
| A Study of Armour® Thyroid Compared to Synthetic T4 (Levothyroxine) in Previously Hypothyroid Participants (NCT04124705) | Allergan | 2019-10-11 |
| Acalabrutinib-Lenalidomide-Rituximab in Patients With Untreated MCL (NCT03863184) | Weill Medical College of Cornell University | 2019-10-11 |
| A Two-Part Infant Study for Early Diagnosis of Respiratory Syncytial Virus (RSV) and Evaluation of JNJ-53718678 in RSV Acute Respiratory Tract Disease (NCT04068792) | Janssen Research & Development, LLC | 2019-10-10 |
| Leveraging Biomarkers for Personalized Treatment of Alcohol Use Disorder Comorbid With PTSD (NCT03667846) | NYU Langone Health | 2019-10-10 |
| Impact of Nicotine Reduction on Adolescent Cigarette Use, Alternative Tobacco Use, and Harm From Tobacco (NCT03860077) | Brown University | 2019-10-10 |
| Efficacy and Safety of JMT103 in Patients With Giant Cell Tumor of Bone (NCT04255576) | Shanghai JMT-Bio Inc. | 2019-10-10 |
| CASCARA: Castration Sensitive Carboplatin, Cabazitaxel and Abiraterone (NCT03934840) | Masonic Cancer Center, University of Minnesota | 2019-10-10 |
| Sintilimab Plus Chemotherapy Followed by dCRT in Locally Advanced ESCC (NCT03985046) | Fudan University | 2019-10-10 |
| DMT310-003 Topical in the Treatment of Acne Vulgaris (NCT04106778) | Dermata Therapeutics | 2019-10-10 |
| Thalidomide, Cyclophosphamide and Dexamethasone for Recurrent/Refractory Adult Langerhans Cell Histiocytosis (NCT04120519) | Peking Union Medical College Hospital | 2019-10-10 |
| National Danish Protocol. Surgery+ SBRT for M1 Prostate Cancer Patients (NCT04086290) | Peter Busch Østergren | 2019-10-10 |
| OLE Study for Patients With Parkinson's Disease With Dementia Enrolled in Study ANAVEX2-73-PDD-001 (NCT04575259) | Anavex Life Sciences Corp. | 2019-10-10 |
| Evaluating the Safety and Efficacy of Inarigivir in Non-cirrhotic Treatment Naive Subjects Infected With Hepatitis B Virus (NCT04059198) | F-star Therapeutics, Inc. | 2019-10-10 |
| Anti-PD-1 +/- RT for MSI-H Solid Tumors (NCT04001101) | University of Colorado, Denver | 2019-10-10 |
| A Safety and Tolerability Study of 10XB-101 Injections in Adult Subjects With Extra Fat Under the Chin ("Double Chin") (NCT04258761) | 10xBio, LLC | 2019-10-10 |
| OLE of Phase 2b/3 Study ANAVEX2-73-AD-004 (NCT04314934) | Anavex Life Sciences Corp. | 2019-10-10 |
| Lactobacillus Johnsonii in Children and Adolescents With T1D (NCT03961854) | University of Florida | 2019-10-10 |
| A Study of Ladiratuzumab Vedotin in Advanced Solid Tumors (NCT04032704) | Seagen Inc. | 2019-10-09 |
| Sintilimab With P-GemOx Regimen for Newly Diagnosed Advanced Extranodal Natural Killer/T-cell Lymphoma, Nasal Type (NCT04127227) | Sun Yat-sen University | 2019-10-09 |
| Study to Evaluate Sacituzumab Govitecan in Combination With Talazoparib in Patients With Metastatic Breast Cancer. (NCT04039230) | Massachusetts General Hospital | 2019-10-09 |
| A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors (NCT03997968) | Cyteir Therapeutics, Inc. | 2019-10-09 |
| De-intensified Radiation Therapy With Chemotherapy (Cisplatin) or Immunotherapy (Nivolumab) in Treating Patients With Early-Stage, HPV-Positive, Non-Smoking Associated Oropharyngeal Cancer (NCT03952585) | National Cancer Institute (NCI) | 2019-10-09 |
| Albendazole Plus High Dose Ivermectin for Trichuriasis in Pediatric Patients (NCT04041453) | Alejandro Krolewiecki | 2019-10-09 |
| Study of rADAMTS-13 (SHP655) in the Treatment of Participants With Acquired Thrombotic Thrombocytopenic Purpura (aTTP) (NCT03922308) | Shire | 2019-10-09 |
| Preliminary Efficacy and Safety of Apremilast in the Treatment of Acne Conglobata (NCT04161456) | Dr. Frank Behrens | 2019-10-09 |
| Melphalan Hydrochloride in Treating Participants With Newly-Diagnosed Multiple Myeloma Undergoing Donor Stem Cell Transplantation (NCT03417284) | M.D. Anderson Cancer Center | 2019-10-09 |
| Ketamine to Improve Recovery After Cesarean Delivery - Part 1 (NCT04037085) | Grace Lim, MD, MS | 2019-10-09 |
| A Clinical Trial to Evaluate AZD7648 Alone and in Combination With Other Anti-cancer Agents in Patients With Advanced Cancers. (NCT03907969) | AstraZeneca | 2019-10-09 |
| Immunotherapy With E7 T Cell Receptor T Cells for Vulvar High-Grade Squamous Intraepithelial Lesions (NCT03937791) | National Cancer Institute (NCI) | 2019-10-09 |
| Treatment Study for Children and Adolescents With Acute Promyelocytic Leukemia (NCT04793919) | Associazione Italiana Ematologia Oncologia Pediatrica | 2019-10-09 |